Related Experiment Video

Updated: Jun 5, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

10.9K

Epitranscriptomic RNA m6A Modification in Cancer Therapy Resistance: Challenges and Unrealized Opportunities

Mohammad Burhan Uddin1, Zhishan Wang2, Chengfeng Yang2,3

  • 1Department of Pharmaceutical Sciences, North South University, Bashundhara, Dhaka, 1229, Bangladesh.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|December 11, 2024
PubMed

Insights

Cancer therapy resistance is a major challenge, but emerging research highlights epitranscriptomics, specifically N6-methyladenosine (m6A) RNA modification, as a key factor. Targeting m6A pathways offers new strategies to overcome treatment resistance and improve patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Cancer therapies like chemotherapy, radiotherapy, and immunotherapy often face challenges due to the development of drug resistance.
  • Tumor recurrence after initial remission can be more aggressive, leading to poor patient survival rates.
  • Existing strategies to overcome therapeutic resistance have shown limited success.

Purpose of the Study:

  • To review recent studies on the role of N6-methyladenosine (m6A) RNA modification and its regulatory proteins in cancer therapy resistance.
  • To discuss the potential of targeting m6A pathways to overcome resistance to various anticancer treatments.
  • To explore the promise and limitations of epitranscriptomic approaches in cancer therapy.

Main Methods:

  • Comprehensive literature review of recent studies on m6A modification in cancer.
  • Analysis of the contribution of m6A regulatory proteins to therapeutic resistance.
  • Discussion of emerging epitranscriptomic mechanisms in cancer progression and treatment response.

Main Results:

  • Dysregulation of m6A RNA modification is an emerging mechanism contributing to cancer therapy resistance.
  • Specific m6A regulatory proteins play significant roles in the development of resistance to chemotherapy, radiotherapy, and targeted therapies.
  • Evidence suggests that targeting m6A pathways can potentially re-sensitize tumors to existing treatments.

Conclusions:

  • Epitranscriptomics, particularly m6A modification, presents a promising new avenue for overcoming cancer therapy resistance.
  • Targeting m6A pathways holds potential for improving treatment efficacy and patient outcomes.
  • Further research is needed to fully understand and exploit the therapeutic potential of targeting m6A modifications while considering limitations.
Keywords:
cancer stem cellcancer therapy resistanceepitranscriptomicsm6A modificationm6A regulator inhibitors

More Related Videos

Methylated RNA Immunoprecipitation Assay to Study m5C Modification in Arabidopsis08:50

Methylated RNA Immunoprecipitation Assay to Study m5C Modification in Arabidopsis

Published on: May 14, 2020

6.6K
Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry08:45

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry

Published on: April 21, 2022

2.3K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.9K
mRNA Stability and Gene Expression02:51

mRNA Stability and Gene Expression

The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
5.5K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.0K